BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16923615)

  • 1. A novel direct competitive repopulation assay for human hematopoietic stem cells using NOD/SCID mice.
    Tatekawa T; Ogawa H; Kawakami M; Oka Y; Yasukawa K; Sugiyama H; Kawase I; Soma T
    Cytotherapy; 2006; 8(4):390-8. PubMed ID: 16923615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
    Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
    Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood.
    Zhang XB; Li K; Fok TF; Li CK; James AE; Lam AC; Lee SM; Yuen PM
    Bone Marrow Transplant; 2002 Nov; 30(9):557-64. PubMed ID: 12407429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice.
    Nitsche A; Junghahn I; Thulke S; Aumann J; Radonić A; Fichtner I; Siegert W
    Stem Cells; 2003; 21(2):236-44. PubMed ID: 12634420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different growth factor requirements for the ex vivo amplification of transplantable human cord blood cells in a NOD/SCID mouse model.
    Bruno S; Gammaitoni L; Gunetti M; Sanavio F; Fagioli F; Aglietta M; Piacibello W
    J Biol Regul Homeost Agents; 2001; 15(1):38-48. PubMed ID: 11388743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions.
    Gunetti M; Ferrero I; Rustichelli D; Berger M; Gammaitoni L; Timeus F; Piacibello W; Aglietta M; Fagioli F
    Exp Hematol; 2008 Feb; 36(2):235-43. PubMed ID: 18206730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient assay for evaluating human thrombopoiesis using NOD/SCID mice transplanted with cord blood CD34+ cells.
    Suzuki K; Hiramatsu H; Fukushima-Shintani M; Heike T; Nakahata T
    Eur J Haematol; 2007 Feb; 78(2):123-30. PubMed ID: 17087740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
    Madlambayan GJ; Rogers I; Purpura KA; Ito C; Yu M; Kirouac D; Casper RF; Zandstra PW
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
    Zheng Y; Sun A; Han ZC
    Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
    Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
    Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells.
    Mazurier F; Doedens M; Gan OI; Dick JE
    Nat Med; 2003 Jul; 9(7):959-63. PubMed ID: 12796774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
    Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
    Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model.
    van Hensbergen Y; Schipper LF; Brand A; Slot MC; Welling M; Nauta AJ; Fibbe WE
    Exp Hematol; 2006 Jul; 34(7):943-50. PubMed ID: 16797422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID/gammac(null) mice.
    Yahata T; Ando K; Miyatake H; Uno T; Sato T; Ito M; Kato S; Hotta T
    Mol Ther; 2004 Nov; 10(5):882-91. PubMed ID: 15509506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34+ cells.
    Hirai M; LaFace D; Robinson S; Kelsey L; Johnson R; Wen SF; Warkentin P; Mills K; Vaillancourt M; Chavez J; Leutzinger C; Sumegi J; Neugebauer S; Lehman J; Talmadge C; Maneval D; Talmadge J
    Cancer Gene Ther; 2001 Dec; 8(12):936-47. PubMed ID: 11781656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential study on the in vivo homing potential of human hematopoietic stem/progenitor cells from different sources in xenotransplanted NOD/SCID mouse model].
    Yang Z; Lu SH; Li YH; Liu B; Wang HJ; Jia HR; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):391-5. PubMed ID: 17939405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem and/or progenitor cells in a nonobese diabetic/Shi-SCID mice serial xenotransplantation model and immune cell activities in vitro: a comparative study of the filter method and the hydroxyethyl starch method.
    Yasutake M; Zheng Y; Inoue-Nagamura T; Akagawa E; Tokushima Y; Terashima S; Takahashi TA
    Transfusion; 2005 Dec; 45(12):1899-908. PubMed ID: 16371042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engraftment kinetics of human CD34+ cells from cord blood and mobilized peripheral blood co-transplanted into NOD/SCID mice.
    Ramírez M; Regidor C; Marugán I; García-Conde J; Bueren JA; Fernández MN
    Bone Marrow Transplant; 2005 Feb; 35(3):271-5. PubMed ID: 15558038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
    Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
    Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.